Science 37’s $1.05 Billion de-SPAC Transaction with LifeSci Acquisition II Corp.

Latham & Watkins LLP represented Science 37 in the transaction.Science 37, Inc. (Science 37), developer of the Decentralized Clinical Trial Operating SystemTM, and LifeSci Acquisition II…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now